The Problem We Refuse to See
For more than a century, we have treated endometriosis as a disease of the pelvis. I think that single assumption is the reason millions of women are still being failed. We are told it affects one in ten women — roughly 190 million worldwide — but that figure rests on a diagnosis that requires surgery to confirm, which means the official count is only ever as large as the number of women we have cut open and caught. I do not believe it is one in ten. I believe it is closer to one in seven, and that even that understates it, because it cannot include the women who never get answers and the women who never come forward at all. When a disease is this common and we still cannot count it, the failure is not in the disease. It is in the way we are looking at it.
And looking at it wrong has a body count. Half of all women who struggle with infertility turn out to have endometriosis, and half of all endometriosis patients face fertility problems of their own. Yet the advice women are still given is to get pregnant, or to have their ovaries removed — to treat a whole-body disease by sacrificing the reproductive system, as though the uterus were the crime scene. Women lose their fertility this way. Women lose their organs. Some women, urged to carry a pregnancy their bodies cannot safely hold, lose their children or their lives. This is what happens when a disease is investigated one symptom at a time instead of as a single whole.
I am a patient-researcher with biopsy-confirmed endometriosis across fourteen surgeries. What follows is my hypothesis, built from what the science already shows and from what my own body has documented over more than a decade. I make two arguments. First, that we have accused the wrong suspect — that endometriosis is not fundamentally a menstrual or pelvic disease but an estrogen-activated autoimmune one, working in two stages. Second, that because it is a whole-body disease, it can be caught before surgery, if we stop hunting for one clue and start reading the whole pattern.
A Disease That Behaves Like Another We Already Understand
Endometriosis behaves far more like multiple sclerosis than like a tumor. It flares and quiets. It strikes different parts of the body in different people. And its damage rarely matches what any single scan can show. We eventually learned to diagnose MS by reading a pattern across the whole nervous system rather than demanding one definitive test — and once we did, we stopped missing it. Endometriosis deserves that same shift in thinking, because it is the same kind of disease: systemic, immune-driven, and stubbornly invisible to any one measurement.
Stage One: The Cells Are Placed, and Estrogen Grows Them
We know from the work of Hugh Taylor’s group at Yale that stem cells travel through the bloodstream and help build endometriosis lesions, and that the lesions actively summon those cells to them (Chen et al., 2021; Moridi et al., 2017). We also know these cells resist the ordinary death that is supposed to clear away any cell that ends up where it does not belong.
My hypothesis begins there. I propose that the first stage of the disease is a signaling error in those cells: instead of dying when they are displaced, they survive, travel, and settle wherever there is injury or estrogen, then grow when estrogen feeds them. A cell whose entire purpose was repair is now following a corrupted instruction, building tissue in the wrong place. At this stage the disease is being quietly assembled. It is not yet doing the thing that puts women on the floor.
How They Get Through the Gate: The Map and the Mask
The question the standard model never answers is how these cells move through the body unchallenged in the first place. My hypothesis is that they are not sneaking past the immune system at all — they are following directions written into their own DNA, like coordinates in a GPS. The instructions say go to a location, and the cell goes. If the map reads liver, it travels to the liver and settles there. To the immune system’s checkpoint, the cell looks like it belongs, because it is doing exactly what its own code tells it to do. The disguise is not a trick laid over the cell. The disguise is the map itself.
That is why the cell passes through the gate untouched during the first stage — it is wearing a legitimate set of directions like a uniform. The break comes with estrogen. When estrogen first reaches the settled cell and activates it, that built-in checkpoint system fails, and the mask comes off — exposing the monster beneath it. This is the hinge between the two stages: the map gets the cell to its hiding place, and estrogen is what finally tears the mask away and starts the war.
This same property explains one of the disease’s most destructive habits, the one surgeons call a frozen pelvis or an endo ball — organs fused into a single mass. These are repair cells, and a repair cell’s nature is to bind tissue together. Because it can break the checkpoint system and mimic more than one kind of cell at once, it can bind to two different organs simultaneously — fusing a bladder to an ovary, an ovary to the bowel — stitching together structures that were never meant to touch. The fused ball is not random scarring. It is a repair cell doing exactly what a repair cell does, in the worst possible place.
Stage Two: The Tissue Bleeds, and the Body Turns on Itself
Once the mask is off and estrogen continues to climb, the misplaced tissue begins to behave like a period in the wrong place — trying to bleed and shed the way a uterine lining does, but trapped, with nowhere to drain. We know estrogen is the switch, because the disease can be grown in men and in animals simply by giving it to them. The tissue becomes a foreign body bleeding in place, cycle after cycle.
Bleeding, dying tissue releases danger signals — including iron from the blood itself — that the immune system is built to detect and destroy. So it attacks. This is exactly where the prevailing theory has it backwards. The standard view holds that the immune system in endometriosis is failing — asleep, unable to clean up the mess. I think the truth is the opposite: the immune system is working precisely as designed, attacking tissue that has bled and flagged itself as a threat. A car’s brakes are not defective because the car slides on ice; they grip exactly as built, on a surface that defeats them. That is what is happening inside these women — the right response, in the wrong place, with no end.
And the lesion does not just sit there waiting to be attacked. It entrenches. It builds its own blood supply and makes its own estrogen, so that even when the cycle ends and the body’s estrogen falls, the lesion keeps feeding itself and keeps bleeding. The evidence of this attack is written into my own surgeries: the pathology from my 2016 and 2020 operations describes pigmented macrophages and giant-cell reactions — in plain terms, immune cells swollen with old blood-iron, and the scarring left where the body fought the same battle again and again.
The Hidden War, and Where It Ends
Here is the part no one is connecting, and it is the part my own body proved. As the lesions disrupt the organs they hold and keep the body in a state of constant low alarm, the strain lands on the adrenal glands. Every flare is a stressor; every cycle is another round. The lesions keep making hormones and keep stressing the system even when estrogen falls, so the adrenals never get to stand down. Given enough time and enough lesions, that relentless demand can grind the adrenal glands until they crash — which is what happened to me. My aldosterone fell to undetectable first; my cortisol followed. A war had been going on beneath my skin for years, and the adrenal collapse was simply the moment the casualties became impossible to ignore.
This reframes what the surgeries were ever doing. They were never a cure — they were damage control, cutting out lesions to stop them from progressing into a frozen pelvis, a catastrophic pregnancy, or outright organ failure. The surgeries held the line on the visible front while the hidden war — on the adrenals, on the autonomic system, on the whole body — went unaddressed, because no one was looking at it as one connected problem.
The Nerve It Was Never Supposed to Reach
My trigeminal nerve is part of this story, and it follows the same rule as everything else. The trigeminal neuralgia came on in 2023, and when it struck, I lost my vision. The nerve pain worsened every time I took my estrogen injection; the same estrogen that activates the disease everywhere else was driving this too. It took roughly six months before I could get the CyberKnife procedure — and the radiation triggered an inflammatory reaction in my head, the kind of exaggerated response I would expect from a body already running an autoimmune disease. Ordinary steroids did not control it. It took another two months before my full vision returned, and I was left with lasting vision impairment and neuropathy. True to the pattern, the cause could not be clearly seen on imaging. I am not claiming this is proven endometriosis in the nerve. I am saying it behaved exactly like the rest of my disease — and to me, it is one more proof that what I am describing is possible.
Why the Pain Never Matches the Disease
Every woman with endometriosis knows the cruelest part of it: the pain has almost nothing to do with how much disease the surgeons find. If placement and immune attack are two separate processes, then pain does not track the amount of tissue — it tracks the ferocity of the attack. My adrenal glands make two different hormones, aldosterone and cortisol, from the same organ. When I developed adrenal failure, they did not fail together: my aldosterone collapsed first, and my cortisol followed later. Two outputs of a single gland, failing on their own timelines. Endometriosis is like that. Growth is one output; immune attack is another. A great deal of tissue under little attack barely hurts. A trace of tissue under furious attack is unbearable. The pain lives in the attack, not in the size.
My Body Argued With the Standard Model, and Won
Two events in my own record contradict the assumptions endometriosis treatment is built on. In 2012, Dr. Tamer Seckin resected an adenomyoma from the wall of my uterus and rebuilt the fundus. When I became pregnant afterward, I bled internally at twelve weeks — half a liter into my abdomen — and no surgeon could find the source. At twenty-six weeks, my uterus ruptured. The placenta had grown straight through that old surgical scar and into my cervix and rectum: placenta percreta. Pregnancy is the highest-progesterone state a body will ever reach, and progesterone is the very hormone we use to suppress this disease. The invasion happened anyway. That tells me the invasive signal is not governed by the hormones we keep prescribing to control it.
The second event is about menstruation. My disease has been confirmed by biopsy across my entire pelvis — the ovarian fossa, the uterosacral ligaments, both ovaries, the endocervix, the sigmoid colon, and tissue grown directly into the muscle wall of my bowel. In 2017, both of my ovaries were removed. In 2019, a remaining fragment was excised. And in 2020, with no ovaries and no menstrual cycle, the disease returned again — confirmed endometriosis and a fresh endometrioma. A disease that comes back after the ovaries are gone is not a menstrual disease. It never was.
We Keep Checking the Organ That Is Only Crying Out
When a woman arrives in pain, we run the obvious checks — we look for inflammation, for internal bleeding, for pregnancy. We test the organ that is sending up the alarm. If her symptoms look like irritable bowel, we go looking inside the colon. The trouble is that the disease is often not inside the organ at all. It is growing on the outside of it. When my symptoms resembled irritable bowel, the disease was growing on the outer wall of my colon, into the muscle, where a scope looking inside would never find it. My appendix was removed with a bloody remnant cyst growing on the back of it. Endometriosis grows on the outside of organs, inflaming them and physically pulling them out of place — which is why a woman can feel like she is dying while every test of the organ’s function comes back normal.
And the alarm that should be ringing loudest is the one we almost never check. The strain of this disease lands on the adrenal stress axis. The meaningful spike is happening there — not only in the standard inflammatory markers we reach for first. With the right test, looking at the adrenal and stress axis and at the exterior of the organs rather than only inside them, I believe this disease would be caught years sooner than it is now.
Why the Standard Bloodwork Tells Women They Are Fine
For years, while my disease was severe and my adrenal system was collapsing, the routine blood tests came back normal — inflammation markers low, sedimentation rate at 2, liver and kidney numbers unremarkable. By every standard measure, I looked healthy. I was not. A test that screens for isolated markers will keep missing a disease whose signal is the relationship between markers — the way the hormones, the immune mediators, the autonomic signs, and the organ patterns all move together over time. A single blood draw is one photograph. This disease is only visible as the whole album.
When they ran the ACTH stimulation test — the test meant to confirm whether the adrenal machinery can respond — the numbers that were supposed to rise did rise. By that test alone, I was technically negative for Addison’s. Yet when my actual cortisol and aldosterone were measured, they were so low I could barely function. The single provoked test passed while my body was collapsing in real time. The exam said the adrenals worked. My life said they were failing. A snapshot cannot catch a war.
The Pattern That Gives the Suspect Away
The profile I propose reads several things at once. The hormonal pattern, sampled across the cycle instead of frozen in a single moment. The immune markers that standard panels leave out entirely, interleukin-6 and interleukin-8 among them. The autonomic and adrenal-stress signs that travel with this disease — in my case a documented dysautonomia, with my oxygen dropping into the sixties and a heart that needed a beta blocker to stay regulated. And the cluster of conditions that ride alongside endometriosis — in my record, interstitial cystitis, migraine, trigeminal neuralgia, and adrenal failure — which mean little in isolation but together form a recognizable signature. Any one of these can be explained away. Together, they name the suspect.
The Cases That Prove We Accused the Wrong One
The strongest evidence that this is not a menstrual disease comes from the cases the old model cannot explain: endometriosis documented in men given estrogen, in infants and fetuses before they could ever menstruate, and in animals only once tissue is introduced and estrogen is present. These are the cases that break the whole theory open, because they prove the disease requires only two things — susceptible cells and estrogen. Not a uterus. Not a period. Not even being female. A diagnosis built on that truth would work for anyone.
How I Would Test This
Three things. First, a timed panel — blood drawn repeatedly across a cycle rather than once, measuring hormones, the immune markers we routinely skip, the adrenal and stress axis, organ markers, and the genetic material that active tissue sheds into the blood — so we can watch the disease move instead of freezing it in a single frame. Second, testing across every estrogen state: before menopause, in menopause without estrogen, and in menopause with estrogen added back — a comparison my own body can provide, since I live in the third state now. Third, a new way to stage the disease — not by counting lesions, which everyone admits does not predict suffering, but by how readily the disease activates and how hard the immune system strikes when it does.
Letting Women Finally See Their Own Disease
And I want a woman to be able to see this disease the way it actually exists inside her — everywhere at once. I imagine a map of the body that lights up where the disease is active and brightens as it spreads: quiet regions in one color, flares in another, adenomyosis in its own, updated in real time from her own measurements. It would take a disease that has been invisible, scattered, and dismissed, and finally make it something a woman and her doctor can see in a single picture.
What I Am Saying
I am proposing that we have spent a century accusing the wrong suspect. Endometriosis is not fundamentally a disease of menstruation or of the pelvis. It is an estrogen-activated autoimmune disease that builds in one stage and attacks in another, in which the attack — not the tissue — is the source of the suffering, and in which the damage runs far past the pelvis, all the way to the adrenal glands and the systems they govern. And because it lives in the whole body, it can be caught there: before surgery, before a decade is lost, before another woman is told to surrender her organs or risk her life to treat a disease that was never only in her pelvis.
It takes only one idea, heard by the right person, to change what we believe about a disease. I intend this to be that idea.
References
Chen P, Mamillapalli R, Habata S, Taylor HS. Endometriosis Cell Proliferation Induced by Bone Marrow Mesenchymal Stem Cells. Reproductive Sciences. 2021;28:426–434.
Moridi I, Mamillapalli R, Cosar E, Ersoy GS, Taylor HS. Bone Marrow Stem Cell Chemotactic Activity Is Induced by Elevated CXCL12 in Endometriosis. Reproductive Sciences. 2017;24:526–533.
World Health Organization. Endometriosis fact sheet (official prevalence ≈ 10% / 190 million; widely acknowledged to be an undercount).
Global prevalence estimates 6–13% (114–247 million); The Lancet meta-analysis, 2023. Infertility association (30–50%). Literature on DAMP/heme-driven innate immune activation and autoimmune classification criteria in endometriosis. [citations finalized at submission]
Author’s surgical, pathology, endocrine, autonomic, and imaging records, 2008–2026 (Greenberg, Seckin, Futoran, Brushwood, Nezhat, Sinervo). Primary source documents.
This work presents a research hypothesis and lived clinical experience. It is not medical advice and is not a substitute for diagnosis or treatment by a qualified physician.